CEACAM5 and colorectal carcinoma: While there are many blood-based biomarkers in existence such as carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA), they suffer from low sensitivity, particularly for early stage CRC [27].